Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Wyeth affirms safety profile of Effexor XR

July 14, 2006

Dose proportionality seen with gabapentin GR

July 14, 2006

Eisai and Teva to end rasagiline collaboration agreement

July 13, 2006

Schizophrenia, depression, etc. targets of newly patented compounds

July 12, 2006

Recent patents report novel vanilloid VR1 receptor antagonists

July 12, 2006

FDA approves Emend for prevention of postoperative nausea and vomiting

July 12, 2006

Approvable letter for Cellegesic

July 12, 2006

Pharmacokinetic profile of Huperzine A prodrug ZT-1 reported

July 11, 2006

DMXB-A improves neurocognition in schizophrenia patients

July 11, 2006

DL-06001 and DL-06002 studied for symptoms of Parkinson's disease

July 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...